Skip to main content
eScholarship
Open Access Publications from the University of California

Universal Screening for Hepatitis C Virus in the ED Using a Best Practice Advisory

  • Author(s): Ford, James S.;
  • Chechi, Tasleem;
  • Toosi, Kavian;
  • Mahmood, Bilawal;
  • Meehleis, Dillon;
  • Otmar, Michella;
  • Tran, Nam;
  • May, Larissa
  • et al.
Abstract

Introduction: In 2019 the United States Preventive Services Task Force (USPSTF) released draft guidelines recommending universal hepatitis C virus (HCV) screening for individuals aged 18-79. We aimed to assess the efficacy of an Emergency Department-based HCV screening program, by comparing screening practices before and after its implementation.

Methods: We performed a retrospective cohort analysis of two temporally-matched, 11-month study periods, corresponding to before and after the implementation of a best practice advisory (BPA). Patients were screened for anti-HCV antibody (Ab) and positive results were followed by HCV viral load (VL) testing. The primary implementation outcome was ED testing volume (number of tests performed/month). The primary screening outcomes were the seroprevalence of anti-HCV Ab and HCV VL. Data were described with simple descriptive statistics.

Results: The median age of patients was similar between periods (pre: 50 years [IQR 34-62], post: 47 years [IQR 33-59]). Patients screened were more likely to be males in the pre-BPA period (Male, pre:60%, post: 49%). During the pre-BPA study period, a total of 69,604 patients were seen in the ED, and 218 unique patients were screened for HCV (mean 19.8 tests/month). During the post-BPA study period, a total of 68,225 patients were seen in the ED, and 14, 981 unique patients were screened for HCV (mean 1,361.9 tests/month). Anti-HCV Ab seroprevalence was 23% (51/218) and 9% (1,340/14,981) in the pre-BPA and post-BPA periods, respectively. In the pre-BPA period, six patients with a positive anti-HCV Ab level had follow-up viral load testing (three were detectable). In the post-BPA period, reflex VL testing was performed in most patients (91%, 1,225/1,340), and there were 563 patients with detectable VLs.

Conclusion: Our study shows that utilizing a universal BPA-driven screening protocol can dramatically increase the number of patients screened for HCV and increase the number of new HCV diagnoses.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View